Erythromycin
- Product NDC
- 50090-4616
- 11-digit product format
- 500904616
- Labeler code
- 50090
- Product ID
- 50090-4616_cb89bd38-a0f0-4439-a91e-c08dda1e4509
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA210954
- Marketing category
- ANDA
- Marketing start
- 2019-07-07
- Marketing end
- 0000-00-00
- Substance
- ERYTHROMYCIN
- Active strength
- 333 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-4616-0 | 50090461600 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (50090-4616-0) | 2019-10-16 | 0000-00-00 | No | No | Current |